Moshe Citronowicz

CIK 1280851 · Sr. V.P. of Operations · last filed 2026-06-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.28M

Companies

Total Filings

Lifetime Open-Market Net

-$833.6K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

BVX price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
APYX	Sr. V.P. of Operations	493,504	$2.59	$1.28M	$0	11	2026-06-15
Apyx Medical Corp (BVX) Delisted	Sr. V.P. of Operations	426,504	—	—	-$833.6K	13	2017-09-27

Recent Filings · Page 2 of 3

24 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2019-02-11	APYX	Grant (A)	—	$0	EDGAR
2017-09-27	Apyx Medical Corp (BVX) Delisted	Grant (A)	—	$0	EDGAR
2015-12-23	Apyx Medical Corp (BVX) Delisted	Buy (P)	+20,000	$36.8K	EDGAR
2012-07-19	Apyx Medical Corp (BVX) Delisted	Grant (A)	—	$0	EDGAR
2011-12-02	Apyx Medical Corp (BVX) Delisted	Other (J)	—	$0	EDGAR
2009-05-13	Apyx Medical Corp (BVX) Delisted	Sell (S)	−13,500	-$100.6K	EDGAR
2009-04-17	Apyx Medical Corp (BVX) Delisted	Sell (S)	−6,500	-$45.9K	EDGAR
2009-04-13	Apyx Medical Corp (BVX) Delisted	Sell (S)	−40,000	-$253.0K	EDGAR
2008-12-08	Apyx Medical Corp (BVX) Delisted	Mixed	+219,491	-$0	EDGAR
2008-09-22	Apyx Medical Corp (BVX) Delisted	Sell (S)	−21,700	-$156.9K	EDGAR

Showing 11–20 of 24

Prev Page 2 of 3 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.